Win-Partners Co Ltd
TSE:3183
Win-Partners Co Ltd
TSE:3183
Price:
1 452
JPY
-0.55%
Market Closed
Market Cap:
¥44.3B
Relative Value
The Relative Value of one
Win-Partners Co Ltd
stock under the Base Case scenario is
1 409.78
JPY.
Compared to the current market price of 1 452 JPY,
Win-Partners Co Ltd
is
Overvalued by 3%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
1 409.78
JPY
Overvaluation 3%
Multiples Across Competitors
Competitors Multiples
Win-Partners Co Ltd Competitors
Win-Partners Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Win-Partners Co Ltd
TSE:3183
|
40.3B JPY | 0.5 | 18.9 | 7.9 | 8.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
116.2B USD | 0.3 | 26.8 | 18.8 | 21.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.4B USD | 0.2 | 42.1 | 14.8 | 18.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
68.6B USD | 0.2 | 42.3 | 14.8 | 18.8 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.7B USD | 0.2 | 31.1 | 15 | 19.5 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.6 | 33.3 | 24.8 | 24.8 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62B CNY | 1.4 | 16.6 | 12.8 | 12.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 21.8 | 10.8 | 15.2 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.5 | 1.5 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
